Dasiglitazone (Dasiglucagon) price and where to buy

Dasiglucagon is currently mainly marketed in the United States under the trade name Zegalogue for the treatment of severe hypoglycemia in patients with type 1 diabetes. Because it is a new generation of glucagon analogues with faster onset of action and higher stability, its market price is relatively high. In the United States, the retail price of a single pre-filled Zegalogue pen usually ranges from $300 to 400. The specific price may vary depending on pharmacies, health insurance coverage, and drug purchase platforms. In addition, some drug manufacturers offer patient assistance programs or coupons to help lower out-of-pocket costs.

In terms of purchase channels, dasiglitazone is mainly sold through hospitals, pharmacies and online medical platforms. Patients can purchase it with a prescription at major chain pharmacies (such as CVS, Walgreens, Rite Aid, etc.), and some hospital pharmacies also provide the drug to meet the needs of urgently needed patients. In addition, with the development of digital health, patients can also purchase through GoodRx, Amazon Pharmacy, Walgreens online and other online pharmacies, and enjoy certain discounts. However, in some areas, purchasing prescription drugs still requires a doctor to issue an electronic prescription and comply with local drug management regulations.

Outside the United States, sales of dasiglitazone vary. The European region is currently awaiting final approval from the European Medicines Agency (EMA), and it is expected that it will be gradually launched in various countries after approval. In Japan, Canada, Australia and other countries, pharmaceutical companies are advancing registration and approval work and have not yet entered large-scale market sales. In these areas where it has not yet been launched, some patients may purchase through cross-border drug purchase, international pharmacies or overseas medical institutions. However, there are certain compliance risks in such channels and they need to be chosen carefully.

For patients who wish to save on the cost of purchasing the drug, some insurance companies and Medicaid programs may partially or fully reimburse the cost of dasiglitazone, especially if it is within the scope of diabetes-related treatments. For example, Medicare and private medical insurance companies in the United States may provide different levels of coverage, and patients should consult their insurance companies to understand reimbursement policies before purchasing drugs. In addition, Zealand Pharma also offers a Patient Assistance Program (PAP), eligible low-income patients can apply for free or discounted drugs. Therefore, patients can compare prices from multiple sources before purchasing, and choose the most appropriate purchase method based on their own medical insurance or assistance plans.

Reference link: https://www.dasiglucagon.com/